March 2020 Clinical Watch Newsletter

April 29, 2020

In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug. Lastly, we review claims data for psychotropic polypharmacy in children.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
Everest Group Services PEAK Matrix for Banking BPS Service Providers Focus on Conduent
Everest Group Services PEAK Matrix for Banking BPS Service Providers Focus on Conduent

Conduent emerged as a Major Contender in the PEAK Matrix and Everest Group identified Conduent to have well...

Next Flipbook
February 2020 Clinical Watch Newsletter
February 2020 Clinical Watch Newsletter

In this issue of Clinical Watch, we discuss COVID-19 and suggest prior authorization criteria for immunothe...